RTTNews | Apr 22, 2021 10:26AM EDT

10:25 Thursday, April 22, 2021 (RTTNews.com) - Renalytix AI plc (RNLX) shares are rising on Thursday morning trade as the company got a 10-year contract from the U.S. General Services Administration to provide KidneyIntelX early-stage kidney disease bio-prognostic testing services.

Currently, shares are at $29.64, up 17.53 percent from the previous close of $25.22 on average volume of 807,302. The shares have traded in a range of $9.91-$32.12 on average volume of 121,351 for the last 52 weeks.

The company noted that when the GSA contract will help KidneyIntelX testing to be available through the Federal Supply Schedule.

Read the original article on RTTNews ( https://www.rttnews.com/3187383/stock-alert-renalytix-gains-17-on-winning-multi-year-contract.aspx)

For comments and feedback: contact editorial@rttnews.com

Copyright(c) 2021 RTTNews.com All Rights Reserved